News & Updates
Filter by Specialty:
Therapeutic heparin may reduce death, bleeding risks in moderate COVID-19
Use of therapeutic heparin does not appear to significantly reduce the death, mechanical ventilation, or intensive care unit (ICU) admission in hospitalized patients with moderate COVID-19 and increased D-dimer levels, reveals a study. However, it is associated with a significantly lower chances of all-cause death and reduced risk of major bleeding.
Therapeutic heparin may reduce death, bleeding risks in moderate COVID-19
26 Oct 2021
Dose-capping chemoradiotherapy tied to higher recurrence in rectal cancer
The risk of disease recurrence is increased among rectal cancer patients treated with dose-capped chemoradiotherapy (CRT), reveals a study. In addition, excessive toxicity has occurred among those dosed by actual body surface area (BSA) compared to patients in the dose-capped group.
Dose-capping chemoradiotherapy tied to higher recurrence in rectal cancer
24 Oct 2021
Prompt antibiotic treatment prevents surgery in preseptal, orbital cellulitis
Differential diagnosis of preseptal and orbital cellulitis show “extremely sensitive” clinical presentation and C-reactive protein (CRP), according to a study, noting that prompt initiation of intravenous antibiotics is required and helps prevent surgical procedures even in those with incipient abscesses.
Prompt antibiotic treatment prevents surgery in preseptal, orbital cellulitis
24 Oct 2021
Kids hard-hit by Delta; which ART performs best?
That COVID-19 mostly spared children might be changing. The Delta variant has taken a severe, unthinkable toll on kids – at least in Arkansas, US, reports an expert at IDWeek 2021.
